Your session is about to expire
← Back to Search
Acupuncture for Pain Management in Lymphoma
Phase 3
Waitlist Available
Led By Gary Deng, MD, PhD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18 or older
Pathological diagnosis of MM, HD or NHL
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 90 days
Awards & highlights
Study Summary
This trial will test whether adding acupuncture to usual pain management can reduce the amount of opioids needed to manage chemotherapy-induced pain, as well as study acupuncture's effects on other cancer treatment symptoms and quality of life.
Who is the study for?
This trial is for adults over 18 who are scheduled for high-dose chemotherapy and stem cell transplant within a month, diagnosed with Multiple Myeloma (MM), Hodgkin's Lymphoma (HD), or Non-Hodgkin's Lymphoma (NHL). They shouldn't be regular opioid users or have had acupuncture recently. People with very low white blood cells, platelets, or certain clotting issues can't join.Check my eligibility
What is being tested?
The study tests if acupuncture can reduce the need for opioids in managing chemotherapy-induced pain in myeloma and lymphoma patients. It compares usual pain management plus acupuncture to usual care alone, also looking at other symptoms and quality of life impacts.See study design
What are the potential side effects?
Acupuncture may cause minor side effects like bruising, bleeding at needle sites, dizziness, or fainting. Opioids can lead to addiction risk, constipation, nausea, drowsiness, confusion and respiratory depression.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I have been diagnosed with multiple myeloma, Hodgkin's disease, or non-Hodgkin's lymphoma.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 90 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 90 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
symptom burden
the number of patients using opioids at a given time
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Usual Care plus AcupunctureExperimental Treatment3 Interventions
Acupuncture will start on Day 0 and continue once daily to Day 15, as long as the patient is inpatient or comes to the clinic for post-transplantation follow-up. to prevent severe pain. If acupuncture does not prevent severe pain, the participant will receive opioid medication as backup pain relief.
Group II: Usual CareActive Control2 Interventions
Will receive only the usual pain management approach, which includes opioid medication when needed for severe pain, according to the routine guidelines for their care.
Find a Location
Who is running the clinical trial?
Memorial Sloan Kettering Cancer CenterLead Sponsor
1,940 Previous Clinical Trials
588,611 Total Patients Enrolled
80 Trials studying Multiple Myeloma
85,867 Patients Enrolled for Multiple Myeloma
Patient-Centered Outcomes Research InstituteOTHER
554 Previous Clinical Trials
29,944,450 Total Patients Enrolled
Hackensack Meridian HealthOTHER
132 Previous Clinical Trials
29,173 Total Patients Enrolled
20 Trials studying Multiple Myeloma
1,120 Patients Enrolled for Multiple Myeloma
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I haven't taken opioids regularly in the last week.I am scheduled for a stem cell transplant within the next month.Your blood tests show very low levels of infection-fighting white blood cells or blood-clotting platelets, or your blood takes longer than normal to clot.I am 18 years old or older.I have not had acupuncture in the last two weeks.I am unable to understand and agree to the study's details on my own.I have been diagnosed with multiple myeloma, Hodgkin's disease, or non-Hodgkin's lymphoma.
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care
- Group 2: Usual Care plus Acupuncture
Awards:
This trial has 2 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger